| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2023 Q3 | Sep 30, 2023 | Trojan Fund from Troy Asset Management | - | - | BDX, DEO, GOOGL, MSFT, NESN.SW, PG, UL, V | Bonds, credit, inflation, interest rates, Multi-Asset, Recession | The manager expects inflation to remain higher and less stable than market participants are used to over the next few years. This will be attended by higher nominal rates, uprooting the valuation yardstick of the past fourteen years. They have added to index-linked holdings to protect against ongoing inflationary risks. | View | |
| 2025 Q2 | Aug 5, 2025 | Auxier Asset Management | 2.5% | 8.7% | ABT, BAC, BDX, BK, BKNG, BRK.B, CAE, CI, ELV, GLW, GOOGL, KR, LINC, MA, META, MSFT, PM, UNH, V, ZBH | AI, Buybacks, healthcare, tariffs, technology, Travel, value | AI disruption has been a growing concern for investors as they are uncertain of long-term consequences. Apple research shows current LLMs only present an illusion of thinking and reasoning, producing results based on patterns rather than true reasoning. The largest tech companies expect to spend over $300 billion on AI infrastructure in 2025 alone. | BKNG GOOGL GOOGL |
View |
| 2025 Q2 | Aug 11, 2025 | BlackRock Mid-Cap Value Fund | 5.6% | 4.9% | BAX, BDX, CAH, CVS, FCNCA, FIS, LHX, SSNC, STM, WDC | AI, dividends, financials, healthcare, Mid-cap, technology, value | Optimism about artificial intelligence endures, with companies emphasizing it in earnings calls and delivering strong results. The fund views AI as a continuing driver of market performance despite broader volatility. | View | |
| 2025 Q2 | Jul 9, 2025 | ClearBridge Investments Dividend Strategy | - | - | AAPL, AVGO, BDX, DIS, GM, LHX, MSFT, NVDA, ORCL, PPG, TEL, TMUS, UNH, V, XOM | AI, defense, diversification, dividends, energy, Quality, valuation, value | The strategy emphasizes dividend-paying companies with the ability to grow dividends significantly over time. Over the last eight years, the average portfolio company has grown its dividend by 7%, well in excess of inflation. Dividend growth is becoming increasingly critical as inflation expectations become more entrenched and stagflation becomes a concern. | ORCL AVGO XOM LHX AVGO XOM LHX |
View |
| 2025 Q2 | Jul 8, 2025 | Mawer International Equity Fund | 6.9% | 17.5% | 267270.KS, BA.L, BDX, FTT.TO, PNG.V, RHM.DE, TVK.TO, UNH | Canada, defense, diversification, Geopolitical, infrastructure, Trade Policy | Defense contractors benefited significantly from heightened geopolitical risks and rising defense spending. Rheinmetall surged over 40% in the quarter, BAE appreciated considerably, and South Korea-based LIG Nex1 saw substantial share price gains due to its strength in precision-guided missile systems. | View | |
| 2025 Q2 | Jul 23, 2025 | Aristotle Atlantic Core Equity Strategy | 14.3% | 7.5% | AAPL, ADPT, AVGO, AWK, BDX, CB, EXPE, HAL, ORCL, TECH, TT, ZTS | AI, Cloud, earnings, healthcare, large cap, technology, Trade Policy, value | President Trump introduced a universal 10% import tariff and reciprocal tariffs on dozens of countries as part of Liberation Day, followed by a 90-day pause on reciprocal tariffs to encourage negotiations. The U.S. and U.K. finalized the Economic Prosperity Deal, while negotiations continued with the EU, Japan, Canada and India. More than 425 companies referenced tariffs in earnings calls and nearly 12% issued negative EPS guidance for the quarter ahead. | AVGO ORCL ZTS EXPE CB BDX AVGO ORCL |
View |
| 2025 Q2 | Jul 22, 2025 | American Century Equity Income Fund | -0.3% | - | AMT, BDX, BK, CRH, CSX, EPD, GOOGL, JNJ, JPM, KVUE, MCHP, MDT, NSC, PCAR, PEP, SATS, UL, UPS | Consumer Staples, Defensive, financials, healthcare, income, Quality, value | The portfolio seeks to invest in companies where the valuation does not reflect the quality and normal earning power of the company. This value-oriented approach has historically resulted in a less volatile portfolio versus the benchmark. | View | |
| 2025 Q2 | Jul 19, 2025 | Aristotle Core Equity Fund | 14.3% | 7.5% | AAPL, ADPT, AVGO, AWK, BDX, CB, EXPE, HAL, ORCL, TECH, TT, ZTS | AI, earnings, large cap, technology, Trade Policy | Strong demand for AI infrastructure and silicon continues to drive performance across Oracle's OCI infrastructure and Broadcom's AI compute and networking business. Customer demand for AI silicon for training and inference remains robust with positive outlook for 2025 and 2026. | AVGO ORCL ZTS EXPE CB BDX AVGO ORCL |
View |
| 2025 Q2 | Jul 15, 2025 | Kovitz Core Equity | 7.9% | 5.4% | ADI, AHT.L, AMZN, BDX, DLTR, FI, FND, HAS, ICE, J, META, MSFT, MSI, ORCL, PM, SCHW, TMO, UMG.AS, V | Cloud, financials, healthcare, tariffs, technology, value | AI sentiment turned negative in Q1 but quickly positive in Q2, with Information Technology sector accounting for 65% of S&P500 returns. The AI theme continues to drive significant market volatility and performance. | FND ADI TMO FI BDX META MSFT ORCL |
View |
| 2023 Q2 | Jul 12, 2023 | Generation Investment Management Global Equity | - | - | AMAT, ASML, BAX, BDX, HSIC, LRCX, MSFT, NVDA, PANW, TXN | AI, Quality, semiconductors, sustainability, technology | Generative AI has entered public consciousness with ChatGPT usage growing rapidly. The technology holds great promise but economic impact will take time as companies experiment with tools. GPU usage is only 7% of servers globally. AI will benefit semiconductor equipment makers and cybersecurity companies while transforming software development. | AMAT |
View |
| 2024 Q2 | Jul 10, 2024 | Generation Investment Management Global Equity | - | - | AMAT, AMZN, AVGO, BDX, CCC, GOOGL, MSFT, NTNX, NVDA, TWLO, VMW, VWS.CO | AI, Cloud, Data centers, energy, Esg, sustainability, technology | Discusses the power demands of Generative AI and its impact on data centers. Notes that AI requires significant electricity for training and inference, with cloud companies investing heavily in AI hardware. Examines sustainability implications of AI's energy consumption. | NTNX |
View |
| 2025 Q2 | Jun 30, 2025 | Oakmark Global Select Fund | 4.5% | - | BABA, BAYRY, BDX, BMW.DE, BN.PA, BNP.PA, COF, DSV.CO, FI, IQV, LLOY.L, PRX.AS | Banking, Electric Vehicles, Europe, Medical Devices, Pharmaceuticals, Trade Policy, value | President Trump's Liberation Day announcement led to significant market volatility, with companies perceived as more exposed to tariffs falling meaningfully while others held up better. The fund actively repositioned during this period, trimming positions that performed well and buying companies where tariff concerns created wider discounts to intrinsic value. | DSV.CO BNP.PA BMW.DE BDX IQV BAYRY |
View |
| 2025 Q2 | Jun 30, 2025 | Oakmark Global Fund | 6.0% | - | 3626.T, ADS.DE, AHT.L, AKZA.AS, ALV.DE, BAYN.DE, BDX, BMW.DE, BNP.PA, BUD, COP, DSV.CO, FI, IQV, KDP, LBRDK, LLOY.L, MOH | financials, global, healthcare, industrials, Logistics, Trade Policy, value | President Trump's Liberation Day announcement led to significant market volatility with companies perceived as more impacted by tariffs falling meaningfully while others held up better. The fund used this volatility to trim positions that performed well and buy companies where the discount to intrinsic value widened significantly. | MOH KDP BNP.PA BMW.DE AHT.L ADS.DE BDX DSV.CO |
View |
| 2025 Q2 | Jun 30, 2025 | FMI All Cap Equity | - | - | BDX, GRG.L, OMF | AI, Bubble, Defensive, Quality, Speculation, Valuations | FMI expresses skepticism about the massive AI capital expenditure cycle, comparing it to the fiber optic overbuild of 2000. While acknowledging AI's long-term potential, they question whether the colossal spending will generate attractive returns, noting that AI monetization remains limited despite nearly $400 billion in annual capex from five mega cap tech companies. | GRG.L BDX OMF MAS NSIT |
View |
| 2025 Q2 | Jun 30, 2025 | FMI International Equity | - | - | BDX, GRG.L, OMF | AI, international, Quality, small cap, Speculation, Valuations, value | While AI has tremendous long-term potential and could be revolutionary, FMI is skeptical about the colossal capital expenditure being deployed. They compare it to the fiber optic overbuild in 2000, where massive overbuilding led to overcapacity. Five mega cap tech companies are on pace to spend nearly $400 billion in capex, yet AI monetization remains limited with AI-native revenues believed to be less than $20 billion total. | GRG.L BDX OMF MAS NSIT |
View |
| 2025 Q2 | Jun 30, 2025 | FMI Large Cap Equity | - | - | BDX, GRG.L, OMF | AI, Bubble, international, Quality, small cap, Valuations, value | While AI has tremendous long-term potential and could be revolutionary, FMI is skeptical about the colossal capital expenditure being deployed. Five mega cap tech companies are on pace to spend nearly $400 billion in capex, with McKinsey forecasting $7 trillion more by 2030. However, AI monetization remains limited with less than $20 billion in AI-native revenues, creating a disconnect between investment and returns. | GRG.L BDX OMF NSIT |
View |
| 2025 Q2 | Jun 30, 2025 | FMI Small Cap Equity | - | - | BDX, GRG.L, OMF | AI, Bubble, Quality, small cap, Speculation, technology, Valuations | While AI has tremendous long-term potential and could be revolutionary, FMI is skeptical about the colossal capital expenditure being deployed. They compare it to the fiber optic overbuild in 2000, where massive overbuilding led to overcapacity. Five mega cap tech companies are on pace to spend nearly $400 billion in capex, yet AI monetization remains limited with AI-native revenues believed to be less than $20 billion total. | GRG.L BDX OMF MAS NSIT |
View |
| 2023 Q2 | Jun 30, 2023 | Trojan Fund from Troy Asset Management | - | 0.6% | BDX, DEO, GOOGL, MSFT, NESN.SW, NVDA, PG, UL, V | AI, asset allocation, credit, interest rates, Multi-Asset, Recession, technology, Valuations | AI represents a significant long-term opportunity for productivity and economic transformation, similar to the internet's impact. However, current market enthusiasm mirrors historical tech bubbles with extreme valuations. The manager expects AI's effects to be wider reaching than current narrow stock price moves suggest, but warns of Pavlovian market responses that will eventually become more nuanced. | GOOGL AAPL|MSFT|NFLX|NVDA|UNH |
View |
| 2026 Q1 | May 6, 2026 | FPA Source Capital | -0.3% | -0.3% | ADI, AON, BDX, CHTR, CMCSA, FBHS, GLEN.L, GOOGL, KMI, KMX, TEL | Balanced, healthcare, international, private credit, SMID Cap, value | View | ||
| 2024 Q1 | May 2, 2024 | Madison Sustainable Equity Fund | 6.1% | 20.1% | A, AAPL, AMZN, BDX, CSCO, GOOGL, LIN, LLY, MFSIX, MFSYX, MSFT, NESN.SW, NKE, NUE, ORCL, PEP, PGR, TGT, UNH, UPS | Esg, growth, healthcare, large cap, sustainability, technology | GLP-1 therapies are in strong demand with limited availability as capacity increases will be skewed towards year-end. Zepbound for Obesity was approved in Q4 2023 and has seen very strong initial demand, but is limited by capacity constraints. | View | |
| 2024 Q1 | May 2, 2024 | Madison Investors Fund | 7.8% | 17.0% | A, ACGL, ACN, ADI, ALC, AMZN, BDX, BRK.B, CHTR, CPRT, DLTR, FI, GOOGL, LBRDK, LOW, PCAR, PGR, PH, TJX, V | financials, growth, industrials, large cap, Quality, technology, value | Two insurers, Arch Capital and Progressive, were large contributors during the quarter. Both are benefiting from attractive market conditions which has boosted underwriting profits. Investment income should continue to rise as they roll over fixed income portfolios at more favorable coupon rates. | PH FISV PGR ACGL PCAR |
View |
| 2025 Q1 | Apr 8, 2025 | Matrix Dividend Income | - | - | ABBV, BDX, BK, CSCO, DG, FI, GNRC, GS, HUM, JPM, LOW, MDT, META, PEP, QCOM, RTX, TGT, TMO, TSN, USB | dividends, financials, healthcare, tariffs, technology, value, volatility | The administration's tariff threats and April 2 Liberation Day 10% tariffs on all imports caused significant market disruption. Tariffs are viewed as policy mistakes that will increase inflation, slow economic growth, and force businesses and consumers to pull back on investments and spending. | TGT PEP GNRC |
View |
| 2025 Q1 | Apr 8, 2025 | Matrix Large Cap Value Strategy | - | - | ABBV, BDX, BK, CSCO, DG, FI, GNRC, GS, HUM, JPM, LOW, MDT, META, PEP, QCOM, RTX, TGT, TMO, TSN, USB | dividends, financials, healthcare, tariffs, technology, value, volatility | The administration's tariff threats and April 2 Liberation Day 10% tariffs on all imports created significant market disruption and economic uncertainty. The manager views these tariffs as a policy mistake that will lead to inflation and economic slowdown, comparing them to an act of war that taxes goods and disrupts the post-war economic system. | TGT PEP GNRC |
View |
| 2026 Q1 | Apr 28, 2026 | FPA Crescent Fund | -1.6% | -1.6% | AON, AZE.BR, BDX, GLEN.L, GOOGL, TEL | healthcare, international, Portfolio Management, SMID Cap, technology, value | View | ||
| 2025 Q1 | Apr 21, 2025 | Kovitz Core Equity | -2.3% | -2.3% | ADBE, ADI, AMAT, AMD, AMZN, ANET, ASHTY, BDX, BRK-A, DEO, FI, GOOG, GOOGL, ICE, J, JPM, MSFT, PM, TMO, UMG.AS | AI, financials, Quality, Resilience, technology, Trade Policy, volatility | New administration's tariff policies creating significant uncertainty with rates of 145% on China and potential decoupling of the two largest global economies. Policy fluidity makes forecasting business fundamentals nearly impossible, causing business leaders and consumers to freeze economic decisions. | MSFT ASHTY ADBE |
View |
| 2026 Q1 | Apr 13, 2026 | The Davenport Value & Income Fund | 1.9% | 1.9% | ACN, BDX, CMCSA, CSCO, CVX, ELV, ENB, FDX, NEE, NSC, NVO, SLB, TXN, UNH, UNP, VSNT, WAT, WY, XOM | AI, dividends, energy, Geopolitical, income, infrastructure, large cap, value | View | ||
| 2025 Q1 | Mar 31, 2025 | American Century Equity Income Fund | 4.7% | 4.7% | BDX, BRK-A, C, CSCO, EPD, JNJ, JPM, KVUE, MCHP, MDT, MLM, NSC, PM, TROW, WFC, XOM | dividends, financials, healthcare, industrials, Quality, value, volatility | The fund continues to focus on higher-quality companies with stable revenues and profits, low indebtedness, stable cash flows and predictable business models that are less sensitive to economic conditions. This approach is driven by continuing inflation and uncertain macroeconomic and policy conditions. | View | |
| 2024 Q1 | Mar 31, 2024 | Trojan Fund from Troy Asset Management | - | - | BDX, DGE.L, GOOGL, HEIA.AS, MSFT, NESN.SW, UL, V | Central Banks, diversification, fiscal policy, gold, inflation, Multi-Asset | Gold has outperformed the S&P 500 this century and reached new all-time highs. The firm has held exposure since 2003, viewing it as essential portfolio insurance that provides diversification and reduces risk. Gold exhibits volatility similar to equities but performs a different function, particularly valuable during market stress. | View | |
| 2023 Q1 | Mar 31, 2023 | Trojan Fund from Troy Asset Management | - | - | BDX, DEO, GOOGL, MSFT, NESN.SW, PG, UL, V | Banking, credit, inflation, Multi-Asset, Passive investing, rates, real estate | Banking failures including SVB, Signature, and Credit Suisse highlight the fragility of the fractional reserve banking model. These events will lead to tighter lending standards and reduced credit availability, particularly affecting small businesses and commercial real estate. | View | |
| 2025 Q4 | Feb 13, 2026 | Hinde Group | -4.0% | 29.5% | BDX, GOOG, IBKR, NBN, NFLX, UBER | AI, Brokerage, Compounding, growth, technology, value | The AI investment boom continues to be an important source of strength for the U.S. economy. Big Tech companies announced plans to spend more than $660 billion on capital expenditures in 2026, mostly for AI chips and data centers, up almost 80% from 2025. The AI investment boom stimulates economic growth through both direct impact of AI-related investments and the wealth effect of soaring values for public and private AI-related equities. Interactive Brokers delivered stellar operating results with total customer accounts and customer equity growing 32% and 37% respectively. Commission revenue grew 26% and net interest income grew 13.2% despite multiple Fed rate cuts. Higher market volatility typically drives increased trading activity among IB's customers, with the VIX averaging 18.97 for 2025. | IBKR |
View |
| 2025 Q4 | Feb 11, 2026 | BlackRock Mid-Cap Value Fund | 2.5% | 13.7% | BAX, BDX, CAH, CVS, FCNCA, FIS, MMS, SSNC, WCC, WDC | AI, dividends, financials, healthcare, industrials, inflation, mid cap, value | Manager notes exuberance driven by artificial intelligence and narrow leadership raises questions about durability. They see value investing as offering a risk-aware way to participate in secular themes, including AI. Large-scale AI-related capital spending could strain power, materials, and construction capacity. The fund explicitly follows a value investing approach, investing in mid-cap companies that pay attractive, sustainable and growing dividends. Manager emphasizes value investing offers a risk-aware way to participate in secular themes and argues for selectivity and disciplined risk control. | View | |
| 2024 Q4 | Dec 31, 2024 | Oakmark Global Fund | -5.8% | 2.5% | A, BAYRY, BDX, CAP.PA, CNC, COF, DSV.CO, DTG.DE, ELV, GM, GOOGL, IPG, MTN | consumer discretionary, Europe, financials, global, healthcare, Restructuring, value | The industry faces headwinds due to mismatches between reimbursement rates and medical costs, but this is expected to prove transitory. Changes to pricing and plan designs will help realign profit trends over time, though a return to normal profitability will take a few years. | MTN ELV DSV.CO BDX BAYRY COF |
View |
| 2024 Q4 | Dec 31, 2024 | Hardman Johnston Large Cap Equity | -1.3% | 17.3% | AMZN, AZN, BDX, CMCSA, ELAN, EW, FTI, GOOGL, IBN, LEN, MA, MELI, MMC, PYPL, SCHW, SLB, SN, STAN.L, SUZKY, TMUS | Data centers, healthcare, interest rates, large cap, technology, Trade Policy | Data center buildout remains strong with companies like Marvell and Vertiv playing key roles. Investment in data centers for artificial intelligence applications was strong during the quarter. Marvell has a strong position in data networking chips in data centers. | LEN MRVL SN |
View |
| 2024 Q4 | Dec 31, 2024 | ClearBridge Investments Large Cap Value | - | - | AVGO, AXP, BAC, BDX, COF, CVS, DE, ELV, INTC, JPM, MCHP, MCK, ORCL, PEP, SRE, TMO, UNH, V, XPO | financials, healthcare, materials, Quality, technology, Utilities, value | The Strategy follows a diversified, valuation-sensitive approach investing in high-quality franchises within durable, growing markets at reasonable valuations. The managers saw a large valuation divergence in 2024 that provided opportunities as high-quality companies weren't attracting capital. They maintained valuation discipline by trimming positions in American Express and JPMorgan Chase due to strong performance. | View | |
| 2023 Q4 | Dec 31, 2023 | Trojan Fund from Troy Asset Management | - | 2.7% | BDX, DEO, GOOGL, HEIA.AS, MSFT, NESN.SW, PG, UL, V | Government Spending, inflation, Multi-Asset, Onshoring, rates, Recession, Valuations | Manager expects persistent inflation driven by increased government spending and fiscal response to future recessions. Real rates likely to fall but nominal rates to stay above 2010s levels. Inflation for goods and services expected on top of asset price inflation. | HEIA.AS |
View |
| 2023 Q2 | Dec 7, 2023 | Madison Investors Fund | 7.8% | 17.0% | ADI, BDX, BLK, CPRT, GOOGL, J, LOW, PCAR, PH, SCHW, TJX, USB | Banking, financials, large cap, Quality, semiconductors, technology | The fund views ChatGPT and AI advancement as interesting but not currently threatening to Alphabet's core search functionality. They believe Alphabet has the technical expertise to counter any emerging AI threats and expect management to make appropriate strategic choices for the long term. | SCHW USB |
View |
| 2025 Q3 | Nov 8, 2025 | Cullen Enhanced Equity Income Fund | 0.9% | 5.4% | AMZN, BAX, BDX, CAG, GOOGL, META, MSFT, NVDA, ORCL, RIO, SW | AI, dividends, Fed, growth, tariffs, technology, value | Euphoria around AI investments has propelled markets higher, with the rebound in the Magnificent 7 pushing valuations to record highs. The trillions of dollars being invested into agentic AI will eventually need to be monetized. Capital expenditures among the top five hyperscalers have surged as these companies race to establish leadership in generative AI. | SPGI |
View |
| 2025 Q3 | Nov 8, 2025 | Cullen Value Fund | 6.8% | 15.9% | AMAT, BAC, BDX, BMY, BWA, C, CI, CMCSA, DIS, JPM, KVUE, LOW, MBGYY, MDLZ, MS, MU, NEE, ORCL, SRE, UNH | AI, dividends, financials, growth, healthcare, technology, value | AI investments have propelled markets higher with euphoria around AI driving the Magnificent 7 to record valuations. Trillions of dollars are being invested into agentic AI that will eventually need to be monetized. Capital expenditures among top hyperscalers have surged as they race to establish leadership in generative AI, creating a self-perpetuating cycle of investment. | UNH SW BDX |
View |
| 2025 Q3 | Nov 16, 2025 | Aristotle Atlantic Core Equity Strategy | 7.1% | 15.1% | ADPT, AMP, AR, AVGO, BDX, BKR, CEG, DAR, DXCM, GH, GOOGL, HAL, ICE, NOW, ORCL | AI, energy, growth, healthcare, large cap, nuclear, technology, Trade Policy | Oracle's transformative growth in cloud infrastructure driven by AI demand, with Oracle Cloud Infrastructure revenue expected to grow through fiscal 2030. The company closed multiple multi-billion-dollar deals including the $30 billion Stargate contract with OpenAI. Natural gas demand is increasing for AI data center power generation, benefiting companies like Antero Resources. | BDX BKR CEG DXCM ADPT ORCL AR DAR |
View |
| 2025 Q3 | Nov 11, 2025 | Hinde Group | 13.9% | 34.9% | AMZN, BDX, GOOG, GOOGL, IBKR, META, MSFT, NFLX, NVDA, UBER, WAT | AI, Buybacks, Capital Allocation, healthcare, Medical Devices, special situations, technology, value | The generative AI investment boom is keeping the economy afloat and stock market ebullient amid political and economic turmoil. Big tech companies like Google, Microsoft, Amazon and Meta plan to spend over $300 billion on AI data centers in 2025, up $100 billion from 2024. Venture capital firms invested $192.7 billion into AI startups through the first nine months of 2025. | BDX |
View |
| 2025 Q3 | Oct 9, 2025 | Mawer International Equity Fund | 3.7% | 21.8% | 0700.HK, AJG, APH, ASML, ATR, BDX, BMO.TO, BNS.TO, BWXT, DB1.DE, FNV.TO, GOOGL, LSEG.L, MLM, MMC, MSFT, RELX.L, RY.TO, SHOP.TO, TD.TO, TME, TSM, VRSK, WAT, WKL.AS | AI, Banking, Canada, gold, rates, semiconductors, technology | AI-related stocks have dominated market returns since ChatGPT's launch in November 2022, accounting for a lion's share of S&P 500 returns, earnings growth, and capital spending. Corporate spending on data center infrastructure and semiconductors is projected to be several trillion dollars over the next three years. AI companies are making enormous investment deals with each other, staying largely within the established AI ecosystem. | View | |
| 2025 Q3 | Oct 28, 2025 | BlackRock Mid-Cap Value Fund | 5.5% | 10.7% | BAX, BDX, CAH, CVS, FCNCA, FIS, MMS, WDC, XBI | dividends, financials, healthcare, mid cap, technology, value | The fund maintains a value-oriented strategy focused on companies with resilient earnings, strong balance sheets, and attractive valuations. This fundamentals-first approach provides a solid foundation and positions portfolios to navigate volatility effectively while seizing opportunities through active management. | View | |
| 2025 Q3 | Oct 22, 2025 | Kovitz Core Equity | - | 8.2% | ADBE, ADI, ALC, AMD, AMZN, ANET, BDX, COO, FI, GOOGL, KMX, META, MSFT, ORCL, PM, PPG, RYAN, TMO, TSLA, WAT | AI, healthcare, infrastructure, momentum, private credit, Quality, technology | The letter extensively discusses AI infrastructure investment with $2.9 trillion projected spending on data centers over three years. Companies like OpenAI have made over $1 trillion in multi-year commitments despite limited current revenue. The AI theme dominates market performance with Information Technology comprising 35% of large cap market weight. | WAT RYAN COO ALC ORCL WAT RYAN COO ALC ORCL |
View |
| 2025 Q3 | Oct 21, 2025 | Hardman Johnston Large Cap Equity | 6.0% | 9.6% | 7269.T, AAPL, ADBE, ADP, AEIS, ALB, AMZN, ASML, AZN, BDX, CMCSA, CTVA, CW, EL, EW, FMC, GOOGL, HWM, HXL, IBN, ILMN, IQV, MA, MDT, META, MMC, MRVL, MSFT, NVDA, OLED, PRY.MI, PYPL, SCHW, SLB, SN, SWK, TMUS, UBER, VRT, VRTX | aerospace, AI, healthcare, industrials, large cap, technology, value | The firm is debating how far artificial intelligence has to run and whether AI-related holdings are bargains, over-extended, or fairly valued. They believe they are at the beginning of a new productivity revolution and suspect current forecasts are too low for companies enabling this revolution. Both Vertiv and Advanced Energy sell power conditioning and management tools into the computing sector and are seeing a surge in business related to the AI buildout. | CTVA VRT PRY AEIS |
View |
| 2025 Q3 | Oct 19, 2025 | American Century Equity Income Fund | 5.3% | - | AMT, BDX, BK, CRH, CSX, EPD, GOOGL, JNJ, JPM, KVUE, MCHP, MDT, NSC, PCAR, PEP, SATS, UL, UPS | Consumer Staples, dividends, financials, healthcare, income, Quality, Utilities, value | The portfolio focuses on higher-quality stocks that may offer resilience amid continuing inflation and uncertain macroeconomic conditions. The team emphasizes companies with stable revenues and profits, low indebtedness, resilient cash flows and predictable business models that are less sensitive to economic conditions. | View | |
| 2023 Q3 | Oct 19, 2023 | Aristotle Core Equity Fund | 2.9% | 21.3% | AAPL, AME, AMZN, AVGO, BDX, CI, GOOGL, JPM, MSFT, NVDA | financials, growth, healthcare, large cap, Quality, technology | View | ||
| 2025 Q3 | Oct 14, 2025 | FMI All Cap Equity | - | - | BDX, GRG.L, OMF | AI, Bubbles, Defensive, Quality, Speculation, Valuations | FMI expresses skepticism about the massive AI capital expenditure cycle, comparing it to the fiber optic overbuild of 2000. While acknowledging AI's long-term potential, they question whether the colossal spending will generate attractive returns, noting that AI monetization remains limited despite nearly $400 billion in annual capex from five mega cap tech companies. | OMF US |
View |
| 2025 Q3 | Oct 14, 2025 | FMI International Equity | - | - | BDX, GRG.L, OMF | AI, Concentration, Defensive, Quality, Speculation, Valuations | FMI expresses skepticism about the massive AI capital expenditure cycle, comparing it to the fiber optic overbuild of 2000. While acknowledging AI's long-term potential, they question whether the colossal spending will generate attractive returns, noting that AI monetization remains limited despite nearly $400 billion in annual capex from five mega cap tech companies. | GRG LN |
View |
| 2025 Q3 | Oct 14, 2025 | FMI Large Cap Equity | - | - | BDX, GRG.L, OMF | AI, Defensive, international, Quality, small cap, Speculation, Valuations | FMI expresses skepticism about the massive AI capital expenditure cycle, comparing it to the fiber optic overbuild of 2000. While acknowledging AI's long-term potential, they question whether the colossal spending will generate attractive returns, noting that AI monetization remains limited despite nearly $400 billion in projected capex from five mega cap tech companies. | BDX US |
View |
| 2025 Q3 | Oct 14, 2025 | FMI Small Cap Equity | - | - | BDX, GRG.L, OMF | AI, Bubble, Defensive, Quality, Speculation, Valuations | FMI expresses skepticism about the massive AI capital expenditure cycle, comparing it to the fiber optic overbuild of 2000. While acknowledging AI's long-term potential, they question whether the colossal spending will generate attractive returns, noting that AI monetization remains limited despite nearly $400 billion in annual capex from five mega cap tech companies. | View | |
| 2024 Q4 | Jan 8, 2025 | Matrix Dividend Income | - | - | AMGN, BDX, BK, CSCO, DG, GILD, HUM, MS, PEP, PNC, UNH | dividends, financials, growth, healthcare, rates, technology, value | Manager expects Value stocks to outperform Growth after more than a decade of underperformance. They anticipate market rotations and regression to the mean for Growth stocks, creating favorable conditions for Value investing. | PEP DG AMGN |
View |
| 2024 Q4 | Jan 8, 2025 | Matrix Large Cap Value Strategy | - | - | AMGN, BDX, BK, CSCO, DG, GILD, HUM, MS, PEP, PNC, UNH | dividends, financials, growth, healthcare, inflation, rates, technology, value | Manager expects Value to outperform Growth after more than a decade of underperformance. They anticipate market rotations in 2025 and a regression to the mean for Growth stocks, creating a favorable environment for Value investing that would provide a tailwind for Matrix's portfolios. | PEP DG AMGN |
View |
| 2025 Q4 | Jan 29, 2026 | FPA Crescent Fund | 3.1% | 17.7% | ADI, AMZN, AVTR, BDX, C, CHTR, CMCSA, CRM, GOOGL, HEIA.AS, IFF, JEF, KMX, META, MSFT, NOW, NTDOY, ORCL, SAF.PA, SAP, SNOW, TEL, WDAY | AI, global, healthcare, Quality, small caps, technology, value | The fund emphasizes being value aware, focusing on cases where both quality and value intersect. They avoid speculative areas where reward for taking risks is insufficient relative to potential returns. The strategy has generated equity-like returns while placing equal importance on capital preservation and appreciation over 30 years. The fund is actively investing in small to mid-cap global securities, believing the investment community is casting its gaze away from these market constituents that offer asymmetric risk-reward for those willing to look forward three to five years. Recent purchases demonstrate their commitment to this thesis. The fund discusses AI extensively through Microsoft's transformation and growth prospects. They analyze how AI/cloud developments transformed Microsoft's business model and examine the massive revenue growth required for current AI valuations to make sense, questioning whether Microsoft can add revenue equivalent to multiple major software companies combined. | MSFT |
View |
| 2025 Q4 | Jan 23, 2026 | American Century Equity Income Fund | 1.8% | 11.9% | BDX, EPD, GOOGL, JNJ, JPM, MCD, MCHP, MDLZ, MDT, MMC, MU, NSC, PEP, PNC, RHHBY, SYY, TFC, UL | Consumer Staples, dividends, financials, healthcare, Quality, value | The fund continues to focus on higher-quality companies with stable revenues and profits, low indebtedness, resilient cash flows and predictable business models that are less sensitive to economic conditions. This approach is viewed as offering resilience amid continuing inflation and uncertain macroeconomic conditions. Healthcare led all sectors in the fourth quarter after being beaten down for much of the year. The fund remains keen on healthcare stocks, particularly those in the healthcare equipment and supplies industry, because they are attractively valued and demand tends to be less susceptible to changes in the economic environment. The fund's investment objective focuses on current income and long-term capital growth, with a strategy of investing in companies believed to be undervalued. The portfolio positioning emphasizes income generation through dividend-paying stocks and preferred securities. | View | |
| 2025 Q4 | Jan 14, 2026 | Hardman Johnston Large Cap Equity | 4.3% | 0.0% | 7269.T, AMZN, AZN, BDX, CCO.TO, CMCSA, EL, EW, GOOGL, HDB, ILMN, IQV, MA, META, MMC, PYPL, SCHW, SLB, SN, TMUS | AI, Genomics, growth, healthcare, large cap, Lithium, technology | AI remains an important driver for portfolio performance, with investments made years ago benefiting from the surge in AI spending. The manager sees AI as particularly relevant in healthcare where it can help achieve both innovation and efficiency while controlling healthcare spending growth. Albemarle is benefiting from a surge in lithium prices due to near-term production disruptions at competitors, improving outlook for global EV penetration, and investment in batteries as energy storage platforms for alternative energy supplies. Illumina, with almost 70% market share in gene sequencing, has weathered a storm of life science funding cuts and competitive entries. While challenges remain, they are well positioned to benefit from any acceleration in clinical and research spending in life sciences. | OLED AEIS ILMN ALB |
View |
| 2024 Q4 | Jan 13, 2025 | Generation Investment Management Global Equity | - | - | ADYEY, AMZN, ASML, BDX, MSFT, NVDA, TSLA, TSM, V, WDAY | AI, Climate, Concentration, long-term, Quality, sustainability, technology | The manager discusses AI as a key driver of market excitement and corporate investment. Microsoft is highlighted as making bold investments in AI with potential to double or triple market share in the AI era. The rise of AI is noted as contributing to increased market speed and volatility. | View | |
| 2024 Q3 | Sep 30, 2024 | Matrix Dividend Income | 0.0% | 0.0% | ABBV, BDX, CMCSA, CSCO, DUK, GS, JPM, MDT, PYPL, QCOM, SBUX, UNP | dividends, financials, healthcare, large cap, rates, value | Matrix's Dividend Income portfolio continues to deliver on its three objectives: generating high current and growing income, downside protection, and capital appreciation. In Q3, three portfolio holdings raised their dividends by an average of 6.1%, and over the past 12 months 23 of 24 holdings increased their dividends by 6.1%. The portfolio maintains a 2.80% dividend yield compared to the S&P 500's 1.28% yield. | NESN.SW BDX MDT |
View |
| 2024 Q3 | Sep 30, 2024 | Matrix Large Cap Value Strategy | 0.0% | 0.0% | ABBV, BDX, CMCSA, CSCO, DUK, GS, JPM, MDT, NESN.SW, PYPL, QCOM, SBUX, UNP | dividends, financials, healthcare, large cap, rates, value | Matrix's Dividend Income portfolio delivered strong performance with 19 holdings raising dividends by 6.4% average in nine months. The portfolio maintains a 2.80% dividend yield versus 1.28% for S&P 500, with 23 of 24 holdings increasing dividends over past 12 months by 6.1% average. | NESN.SW BDX MDT |
View |
| 2024 Q3 | Sep 30, 2024 | Hardman Johnston Large Cap Equity | 4.9% | 18.8% | 7269.T, AMZN, AZN, BDX, CMCSA, ELAN, EW, FTI, GOOGL, IBN, ILMN, MA, MELI, MMC, PYPL, SCHW, SLB, STAN.L, TMUS, XRAY | aerospace, AI, healthcare, large cap, rates, technology | The Federal Reserve cut interest rates by 0.5% in September, signaling a change in direction for major parts of the economy. After years of rapidly rising rates, this change will affect mortgage rates, credit card balances, savings, and business operations. Major sectors that have been moribund, especially housing, will have a chance to help the next expansion cycle get underway. | View | |
| 2024 Q3 | Sep 30, 2024 | American Century Equity Income Fund | 9.6% | 0.0% | BDX, EPD, INTC, JNJ, JPM, KVUE, MCHP, MDT, NSC, ON, PG, RB.L, TROW, UNH, VZ, XOM | Consumer Staples, dividends, financials, healthcare, income, Quality, Utilities, value | Value stocks outperformed growth stocks across the market-capitalization spectrum during the quarter. The portfolio seeks to invest in companies where the valuation does not reflect the quality and normal earning power of the company. | View | |
| 2024 Q2 | Jul 17, 2024 | Madison Investors Fund | 7.8% | 17.0% | A, ACGL, ADI, ALC, AMZN, BDX, BRK.B, CPRT, DE, DLTR, FI, GOOGL, LOW, PCAR, PGR, PH, SBUX, TJX, TXN, V | consumer, industrials, insurance, large cap, Quality, semiconductors, technology, value | Semiconductor manufacturers Analog Devices and Texas Instruments continue to see declining sales and profits due to weak demand and inventory reduction by customers and distributors. However, the cycle appears to be bottoming, setting conditions for a profit rebound over the coming years as investors better appreciate the industry's secular demand characteristics. | DE SBUX |
View |
| 2024 Q2 | Jun 30, 2024 | American Century Equity Income Fund | 9.6% | 0.0% | ADI, BDX, CB, EPD, INTC, JNJ, JPM, KMB, KVUE, MCHP, MDT, NSC, RHHBY, TXN, UL, VZ, XOM | Consumer Staples, dividends, financials, Quality, technology, Utilities, value | The portfolio focuses on higher-quality stocks with stable revenues and profits, low indebtedness, stable cash flows and predictable business models that are less sensitive to economic conditions. This approach is viewed as offering resilience against uncertain economic environments and lagging effects of elevated interest rates. | View | |
| 2023 Q1 | May 23, 2023 | ClearBridge Investments Large Cap Value | 0.0% | 0.0% | AXP, BAC, BDX, COP, CVX, DISH, ELV, GOOGL, HON, JNJ, JPM, MCK, META, MSFT, MSI, PGR, SCHW, TEL, UNH, USB | Banking, financials, healthcare, large cap, Quality, technology, value | The banking crisis in March highlighted risks in less diversified banks with concentrated deposit bases. The strategy's bias toward larger banks with strong deposit bases provided defensive positioning during the selloff. | MCK ADI|BDX|FI|FND|HAS|META|MSFT|MSI|ORCL|TMO ADI|BDX|FI|FND|HAS|META|MSFT|MSI|ORCL|TMO AVGO|LLY|MRK|NVDA|ORCL|PGR SCHW |
View |
| 2023 Q1 | Apr 14, 2023 | Madison Investors Fund | 7.8% | 17.0% | ADI, BDX, BLK, CPRT, GOOGL, J, LOW, PCAR, PH, SCHW, TJX, USB | Banking, financials, large cap, Quality, semiconductors, technology, value | The fund views ChatGPT and AI advancement as interesting but not currently threatening to Alphabet's core search functionality. They believe Alphabet has the technical expertise to counter any emerging threats and expect management to make sound strategic choices for the long term. | SCHW USB |
View |
| 2025 Q1 | Mar 31, 2025 | Hardman Johnston Large Cap Equity | -6.5% | -6.5% | AMZN, AZN, BDX, CMCSA, GOOGL, HWM, HXL, IBN, MA, META, MMC, MRVL, PYPL, SCHW, SLB, SN, STAN.L, TMUS, VRT, VRTX | aerospace, AI, growth, tariffs, technology, volatility | The portfolio was significantly impacted by AI-related volatility following DeepSeek's R1 model release, which pressured AI compute and networking supply chains. Despite the selloff in holdings like Marvell and Vertiv, the manager believes the immediate reaction was an overreaction and that reasoning models should drive greater hardware demand over time. | View | |
| 2023 Q4 | Mar 1, 2024 | ClearBridge Investments Dividend Strategy | 0.0% | 0.0% | AAPL, AMT, AVGO, AZN, BDX, CHK, CSCO, ENB, GILD, INTC, JPM, MSFT, PFE, PSA, SRE, WMB, XOM | AI, dividends, healthcare, inflation, Pipelines, rates, technology, Utilities | The strategy focuses on high-quality dividend growers as a core investment approach. Growing dividends are positioned as one of investors' few tools for combating inflation and rising interest rates, preserving and expanding purchasing power when dividends grow faster than inflation. | AZN GILD AAPL AAPL|MSFT|NFLX|NVDA|UNH |
View |
| 2023 Q4 | Feb 26, 2024 | Aristotle Core Equity Fund | 2.9% | 21.3% | AAPL, AME, AMZN, AVGO, BDX, BMY, COST, GOOGL, HAL, JPM, LLY, META, MSFT, NVDA, PEP, SPR, VRTX | AI, growth, healthcare, large cap, Pharmaceuticals, technology, value | The fund benefited from AI-driven performance, particularly through Broadcom's strength in AI business segments. The broader market's 2023 gains were primarily driven by the seven largest companies, with AI being a key factor in their outperformance. | MELI|NFLX|ORCL|TCOM|VRTX|YUMC ALLY |
View |
| 2023 Q4 | Feb 26, 2024 | Aristotle Atlantic Core Equity Strategy | 3.1% | 21.7% | AR, AVGO, BDX, BMY, CHH, DAR, EXPE, HAL, LLY, NOW, PEP, SPR, TFX, VRTX | earnings, energy, healthcare, large cap, technology, value | Broadcom reported strength in its AI business segments during Q4. The company provided positive fiscal year 2024 guidance that included synergy target goals ahead of schedule for the combined businesses following the VMware acquisition. | MELI|NFLX|ORCL|TCOM|VRTX|YUMC ALLY |
View |
| 2023 Q4 | Jan 14, 2024 | Madison Sustainable Equity Fund | 6.1% | 20.1% | A, AAPL, AMT, BDX, COST, EL, GOOGL, J, JPM, LIN, LLY, MSFT, ORCL, PG, QCOM, TGT, UNH, USB, V, VLTO | financials, healthcare, inflation, large cap, rates, Sustainable, technology | Interest rates dropped during the fourth quarter as inflation moderated and the market began to discount an end to Fed rate hikes and even began discounting interest rate cuts in 2024. The shift in the yield curve in the latter part of 2023 may have overly discounted forthcoming interest rate cuts. Fed Fund Futures point to 150 basis points of rate cuts by the end of 2024 to 3.85%, which is more aggressive than the Federal Reserve's 75 basis point cut median estimate. | View | |
| 2023 Q4 | Jan 14, 2024 | Madison Investors Fund | 7.8% | 17.0% | A, ACGL, ALC, BDX, BN, CHTR, DHR, DLTR, GOOGL, LBRDK, SCHW, TXN, USB, VEEV | financials, healthcare, large cap, Quality, technology, value | The fund added to Texas Instruments following share price weakness amid investor wariness of the analog semiconductor downcycle and negative margin impact from capital investment programs. Management expects end markets to grow above GDP rates long-term and capital investments to generate attractive returns. | View | |
| 2023 Q4 | Jan 2, 2024 | Diamond Hill Large Cap Strategy | 7.9% | 14.7% | AAPL, AIG, ALL, AMZN, BAC, BDX, BWA, CARR, CVX, GOOGL, HON, KKR, META, MSFT, NVDA, PFE, TGT, TSLA, UNP | energy, financials, large cap, Quality, rates, technology, value | The fund focuses on finding good companies with solid fundamentals trading at attractive discounts to intrinsic value estimates. They emphasize their rigorous, bottom-up approach to identifying compelling investing opportunities despite market uncertainty. | View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Fund Letters | Oakmark Global Select Fund | Becton, Dickinson and Company | Health Care | Health Care Equipment | Bull | NYSE | diagnostics, healthcare, innovation, Laboratory Equipment, manufacturing, Medical devices, medical technology | View Pitch |
| Apr 13, 2026 | Fund Letters | Oakmark Global Fund | Becton, Dickinson and Company | Health Care | Health Care Equipment | Bull | NYSE | China, Healthcare Equipment, innovation, manufacturing, Margins, Medical devices, operational improvements, pharmaceuticals | View Pitch |
| Apr 13, 2026 | Fund Letters | FMI International Equity | Becton Dickinson & Co. | Health Care | Health Care Equipment | Bull | NYSE | business separation, Consumables, defensive, Healthcare Equipment, Healthcare Utilization, Manufacturing Scale, margin expansion, Medical devices, oligopoly, recurring revenue | View Pitch |
| Apr 13, 2026 | Fund Letters | FMI Small Cap Equity | Becton Dickinson & Co. | Health Care | Health Care Equipment | Bull | NYSE | business separation, Consumables, defensive, growth, Healthcare Equipment, Manufacturing Scale, Medical devices, oligopoly, Quality, recurring revenue | View Pitch |
| Apr 13, 2026 | Fund Letters | FMI Large Cap Equity | Becton Dickinson & Co. | Health Care | Health Care Equipment | Bull | NYSE | business separation, Consumables, healthcare, Healthcare Equipment, Manufacturing Scale, Medical devices, oligopoly, recurring revenue | View Pitch |
| Apr 13, 2026 | Fund Letters | Kovitz Core Equity | Becton Dickinson and Company | Health Care Equipment & Supplies | Health Care Equipment | Bull | NYSE | defensive, Demographics, healthcare, Medical devices, recurring revenue, Value | View Pitch |
| Apr 13, 2026 | Fund Letters | FMI All Cap Equity | Becton Dickinson & Co. | Health Care | Health Care Equipment | Bull | NYSE | business separation, Consumables, Defensive growth, healthcare, Healthcare Equipment, Manufacturing Scale, Medical devices, oligopoly | View Pitch |
| Apr 13, 2026 | Fund Letters | Oakmark Global Fund | Becton, Dickinson and Company | Health Care | Health Care Equipment | Bull | NYSE | Healthcare Equipment, innovation, Manufacturing Scale, market leader, medical technology, valuation opportunity | View Pitch |
| Apr 13, 2026 | Fund Letters | Matrix Dividend Income | Becton Dickinson | Health Care Equipment & Services | Health Care Equipment | Bull | NYSE | Acquisitions, Critical Care, Earnings Accretive, Equity, healthcare, Medical devices, Value | View Pitch |
| Apr 13, 2026 | Fund Letters | Matrix Large Cap Value Strategy | Becton Dickinson | Health Care Equipment & Services | Health Care Equipment | Bull | NYSE | Acquisitions, Critical Care, earnings beat, healthcare, Medical devices, medical technology, Value | View Pitch |
| Jan 15, 2026 | Seeking Alpha | Seeking Alpha | Becton, Dickinson and Company | Healthcare | Medical Instruments & Supplies | Bull | New York Stock Exchange | Becton, Dickinson, bioscience, debt reduction, diagnostics, divestment, equity stake, organic growth, shareholder value, strategic acquisition, Waters Corporation | View Pitch |
| Jan 13, 2026 | Seeking Alpha | Seeking Alpha | Becton, Dickinson & Co. | Medical Technology | Medical Devices | Bull | New York Stock Exchange | cash flow, Connected care, dividend yield, global reach, innovation, life sciences, medical technology, ROIC, total return, Undervalue | View Pitch |
| Dec 6, 2025 | Fund Letters | Julien Albertini | Becton, Dickinson and Company | Health Care | Medical Instruments & Supplies | Bull | NYSE | buybacks, Devices, diagnostics, dividends, Medtech | View Pitch |
| Dec 3, 2025 | Fund Letters | Owen Fitzpatrick | Becton, Dickinson and Company | Health Care | Health Care Supplies | Bear | NYSE | diagnostics, Funding, growth, guidance, Margins, Medtech, Policy, tariffs | View Pitch |
| Dec 3, 2025 | Fund Letters | Owen Fitzpatrick | Becton, Dickinson and Company | Health Care | Health Care Supplies | Bear | NYSE | diagnostics, Funding, growth, guidance, Margins, Medtech, Policy, tariffs | View Pitch |
| Nov 29, 2025 | Fund Letters | James Cullen | Becton, Dickinson and Company | Health Care | Medical Instruments & Supplies | Bull | NYSE | Consumables, deleveraging, Margins, Medtech, restructuring | View Pitch |
| Nov 29, 2025 | Fund Letters | Marc Werres | Becton, Dickinson and Company | Health Care | Medical Instruments & Supplies | Bull | NYSE | Consumables, deleveraging, Margins, Medtech, restructuring | View Pitch |
| Nov 29, 2025 | Fund Letters | Owen Fitzpatrick, Thomas Hynes, Jr, Brendan O’Neill | Becton, Dickinson and Company | Health Care | Medical Instruments & Supplies | Bear | NYSE | de-risking, divestiture, Funding, guidance, Medtech | View Pitch |
| Aug 8, 2025 | Seeking Alpha | The Value Investor | Becton, Dickinson and Company | Health Care | Medical Instruments & Supplies | Bull | NYSE | — | View Pitch |
| Aug 7, 2025 | Seeking Alpha | Harris Oakmark | Becton, Dickinson and Company | Health Care | Medical Instruments & Supplies | Bear | NYSE | — | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| Mark A. Hillman | Hillman Value Fund | $158.9M | $2.8M | 1.74% | 14,230 | -2,584 | -15.37% | 0.0042% |
| Paul Tudor Jones | Tudor Investment Corp | $53.4B | $1.6M | 0.00% | 8,400 | -105,800 | -92.64% | 0.0025% |
| Steven A. Cohen | Point72 Asset Management | $86.8B | $6.2M | 0.01% | 32,000 | +30,200 | +1677.78% | 0.0094% |
| Jeffrey Smith | Starboard Value | $5.3B | $180.5M | 3.42% | 929,917 | -278,081 | -23.02% | 0.2729% |
| Ray Dalio | Bridgewater Associates | $27.4B | $1.8M | 0.01% | 9,039 | -462 | -4.86% | 0.0027% |
| Dmitry Balyasny | Balyasny Asset Management | $76.6B | $55.0M | 0.07% | 283,606 | -166,394 | -36.98% | 0.0832% |
| Israel Englander | Millennium Management LLC | $233.2B | $7.2M | 0.00% | 37,300 | -7,300 | -16.37% | 0.0109% |
| Jeremy Grantham | GMO LLC | $39.1B | $1.1M | 0.00% | 5,600 | +0 | +0.00% | 0.0016% |
| Terrence Murphy | Clearbridge Investments | $124.9B | $794.2M | 0.64% | 4,092,337 | -314,650 | -7.14% | 1.2008% |
| David Siegel & John Overdeck | Two Sigma Investments | $67.5B | $7.1M | 0.01% | 36,559 | +1,566 | +4.48% | 0.0107% |
| Cliff Asness | AQR Capital Management | $190.6B | $230.4M | 0.12% | 1,186,943 | +153,083 | +14.81% | 0.3483% |
| Oliver Murray | Brandes Investment | $13.1B | $238.7M | 1.82% | 1,229,707 | +77,104 | +6.69% | 0.3608% |
| Charles Mawer | Mawer Investment Management | $17.9B | $105.4M | 0.59% | 543,136 | -522,870 | -49.05% | 0.1594% |
| Mario Gabelli | GAMCO Investors | $10.4B | $1.8M | 0.02% | 9,474 | -96 | -1.00% | 0.0028% |
| Cory Martin | Barrow, Hanley, Mewhinney & Strauss | $30.0B | $1.0M | 0.00% | 5,391 | +0 | +0.00% | 0.0016% |
| Rich Handler | Jefferies | $19.3B | $1.9M | 0.01% | 10,028 | +10,028 | +100.00% | 0.0029% |
| Richard Kayne & John Anderson | Kayne Anderson Rudnick Investment Management | $37.3B | $16,690 | 0.00% | 86 | -11 | -11.34% | 0.0000% |